drugset
Drugs / Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells
last change Nov 2023 re-read 3 minutes ago

Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells

Cell therapy

Developed for
bronchopulmonary dysplasia
Investigated by
Canadian Institutes of Health Research (CIHR) · Ontario Institute for Regenerative Medicine · Ottawa Hospital Research Institute · Stem Cell Network

Trials 1

today NCT04255147 · Ph 1
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04255147 Oct 2022 → Nov 2023 overdue bronchopulmonary dysplasia Ottawa Hospital Research Institute Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT04255147 ↗
Modality Cell therapy “Cell therapy” NCT04255147 ↗
Route Intravenous “administered intravenously” NCT04255147 ↗